Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,528 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Impact of Point-of-Care Ultrasound-Guided Resuscitation on Clinical Outcomes in Patients With Shock: A Systematic Review and Meta-Analysis.
Basmaji J, Arntfield R, Desai K, Lau VI, Lewis K, Rochwerg B, Fiorini K, Honarmand K, Slessarev M, Leligdowicz A, Park B, Prager R, Wong MYS, Jones PM, Ball IM, Orozco N, Meade M, Thabane L, Guyatt G. Basmaji J, et al. Among authors: lewis k. Crit Care Med. 2024 Sep 18. doi: 10.1097/CCM.0000000000006399. Online ahead of print. Crit Care Med. 2024. PMID: 39298556
Impact of a University-Led COVID-19 Case Investigation and Contact Tracing Program.
Siira M, Harrington KRV, Lewis K, Rothschild E, Graham T, Rabinovitz SR, Shartar S, Milazzo T, Crubezy M, Olsen A, Clark D, Isakov A, Chamberlain A, Gelaye E, Xing M, Patimeteeporn C, Cegielski JP, Gandhi NR. Siira M, et al. Among authors: lewis k. J Public Health Manag Pract. 2024 Sep 13. doi: 10.1097/PHH.0000000000002067. Online ahead of print. J Public Health Manag Pract. 2024. PMID: 39269522
Case report: Deep sequencing and long-read genome sequencing refine prior genetic analyses in families with apparent gonadal mosaicism in PIK3CD-related activated PI3K delta syndrome.
Orellana H, Yan J, Paul A, Tokita M, Ding Y, Ghosh R, Lewis KL, Davis J, Jamal L, Jodarski C, Similuk M, Saucier N, Zhu Z, Wang Y, Wu S, Ruggieri J, Su HC, Uzel G, Nahas S, Cooper M, Walkiewicz MA. Orellana H, et al. Among authors: lewis kl. Front Immunol. 2024 Aug 26;15:1451212. doi: 10.3389/fimmu.2024.1451212. eCollection 2024. Front Immunol. 2024. PMID: 39253077 Free PMC article.
A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of Groups 1, 2, and 3, and primary analysis of fixed-dose treatment Group 6.
Hughes BGM, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, Grob JJ, Lewis KD, Ansstas G, Day F, Ladwa R, Stein BN, Muñoz Couselo E, Meier F, Hauschild A, Schadendorf D, Basset-Seguin N, Modi B, Dalac-Rat S, Dunn LA, Flatz L, Mortier L, Guégan S, Heinzerling LM, Mehnert JM, Trabelsi S, Soria-Rivas A, Stratigos AJ, Ulrich C, Wong DJ, Beylot-Barry M, Bossi P, Bugés Sánchez C, Chandra S, Robert C, Russell JS, Silk AW, Booth J, Yoo SY, Seebach F, Lowy I, Fury MG, Rischin D. Hughes BGM, et al. Among authors: lewis kd. J Am Acad Dermatol. 2024 Sep 6:S0190-9622(24)02770-1. doi: 10.1016/j.jaad.2024.06.108. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 39245360
2,528 results